Abstract
Hypothermic machine perfusion (HMP) of kidneys is a long-established alternative to static cold storage and has been suggested to be a better preservation method. Today, as our deceased donor profile continues to change towards higher-risk kidneys of lower quality, we are confronted with the limits of cold storage. Interest in HMP as a preservation technique is on the rise. Furthermore, HMP also creates a window of opportunity during which to assess the viability and quality of the graft before transplantation. The technology might also provide a platform during which the graft could be actively repaired, making it particularly attractive for higher-risk kidneys. We review the current evidence on HMP in kidney transplantation and provide an outlook for the use of the technology in the years to come.
| Original language | English |
|---|---|
| Pages (from-to) | 665-676 |
| Number of pages | 12 |
| Journal | Transplant International |
| Volume | 28 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun-2015 |
| Externally published | Yes |
Keywords
- delayed graft function
- donation after brain death
- donation after circulatory death
- expanded criteria donors
- extended criteria donors
- graft quality
- history of machine perfusion
- hypothermic machine perfusion
- kidney transplantation
- organ preservation
- perfusate biomarkers
- renal resistance
- viability assessment
- STATIC COLD-STORAGE
- ISCHEMIA-REPERFUSION INJURY
- MESENCHYMAL STEM-CELLS
- DELAYED GRAFT FUNCTION
- HEART-BEATING DONORS
- VIVO NORMOTHERMIC PERFUSION
- RANDOMIZED CONTROLLED-TRIAL
- EXPANDED CRITERIA DONORS
- RENAL-TRANSPLANTATION
- PULSATILE PERFUSION